Johannes F E Mann

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Clinical Practice

Epidermal Growth Factor Receptor

Cardiovascular Disease

Top Venues

Nature medicine

Diabetes, obesity & metabolism

Clinical journal of the American Society of Nephrology : CJASN

This page only lists publications with an associated author ORCID identifier.

Publications

Johannes F E Mann, Ellen Burgess, George Bakris, Nicolas Belmar, Heidrun Bosch-Traberg, Robert Busch, David M Charytan, Samy Hadjadj, Pieter Gillard, Jose Luis Gorriz Teruel, Thomas Idorn, Xiantong Zou, Kenneth W Mahaffey, Vlado Perkovic, Søren Rasmussen, Roland Erich Schmieder, Richard E Pratley, Katherine R Tuttle
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial. Nature medicine (2024)
Johannes F E Mann, Ellen Burgess, George Bakris, Nicolas Belmar, Heidrun Bosch-Traberg, Robert Busch, David M Charytan, Samy Hadjadj, Pieter Gillard, Jose Luis Gorriz Teruel, Thomas Idorn, Xiantong Zou, Kenneth W Mahaffey, Vlado Perkovic, Søren Rasmussen, Roland Erich Schmieder, Richard E Pratley, Katherine R Tuttle
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial. Nature medicine (2024)
Darren K McGuire, Rodica P Busui, John Deanfield, Catherine M Viscoli, Johannes F E Mann, Nikolaus Marx, Sharon L Mulvagh, Neil Poulter, Mads D M Engelmann, G Kees Hovingh, Maria Sejersten Ripa, Mette Gislum, Kirstine Brown-Frandsen, John B Buse
Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: SOUL, a randomized trial, design and baseline characteristics. Diabetes, obesity & metabolism (2023)
Sadaf G Sepanlou, Johannes F E Mann, Philip Joseph, Prem Pais, Peggy Gao, Maryam Sharafkhah, Gholamreza Roshandel, Salim Yusuf, Reza Malekzadeh
Fixed-Dose Combination Therapy for Prevention of Cardiovascular Diseases in CKD: An Individual Participant Data Meta-analysis. Clinical journal of the American Society of Nephrology : CJASN (2023)
Frederik Persson, Stephen C Bain, Ofri Mosenzon, Hiddo J L Heerspink, Johannes F E Mann, Hiddo J Lambers Heerspink, Itamar Raz, Itamar Raz, Søren Rasmussen, Bernt Johan von Scholten, Ellen Burgess, null null
Changes in Albuminuria Predict Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Post Hoc Analysis of the LEADER Trial. Diabetes care 44 (4) (2021)
Johannes F E Mann, Tara I Chang, William C Cushman, Susan L Furth, Joachim H Ix, Fan Fan Hou, Gregory A Knoll, Paul Muntner, Roberto Pecoits-Filho, Mark J Sarnak, Charles R V Tomson, Jonathan C Craig, David J Tunnicliffe, Martin Howell, Marcello Tonelli, Michael Cheung, Amy Earley, Alfred K Cheung
Commentary on the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in CKD. Current cardiology reports 23 (9) (2021)
Johannes F E Mann, John B Buse, Thomas Idorn, Lawrence A Leiter, Richard E Pratley, Søren Rasmussen, Tina Vilsbøll, Benjamin Wolthers, Vlado Perkovic
Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis. Diabetes, obesity & metabolism 23 (9) (2021)